A recent Fact.MR report forecasts the global cellulose derivative excipient market to reach US$ 341 million in 2024, with an expected CAGR of 5.9% from 2024 to 2034. Pharmaceutical companies increasingly favor cellulose derivatives for their exceptional binding properties, controlled release, and enhanced stability, which make them ideal for developing effective, patient-friendly drug...